Key Developments: McKesson Corp (MCK)
117.31USD
24 May 2013
$0.03 (+0.03%)
$117.28
$116.79
$117.64
$116.09
665,528
1,331,976
$119.32
$84.65
Latest Key Developments (Source: Significant Developments)
McKesson Corp Issues FY 2014 EPS Guidance In Line With Analysts' Estimates
McKesson Corp announced that for fiscal 2014, it expects adjusted Earnings per diluted share (EPS) of $7.90 to $8.20. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $8.06 for fiscal 2014. Full Article
McKesson Corp Completes Acquisition of Pss World Medical Inc
McKesson Corp announced that it completed the previously announced acquisition of Pss World Medical Inc for a total purchase price of approximately $2.1 billion. Full Article
McKesson Corp Lowers FY 2013 EPS Guidance
McKesson Corp announced that for fiscal 2013, it expects adjusted Earnings per diluted share (EPS) of $7.10 to $7.30. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $7.30 for fiscal 2013. Full Article
McKesson Corp Quarterly Dividend January 30, 2013
McKesson Corp announced that it has declared a regular dividend of $0.20 per share on Common Stock, payable on April 1, 2013, to stockholders of record on March 1, 2013. Full Article
McKesson Corp Announces Early Termination of Hart-Scott-Rodino Act Waiting Period for Acquisition of PSS World Medical Inc
McKesson Corp announced that it has received notification of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the proposed acquisition of PSS World Medical Inc. The termination of this waiting period satisfies one of the conditions for McKesson`s proposed acquisition of PSS World Medical. The transaction remains subject to other customary closing conditions, including approval by the shareholders of PSS World Medical. Subject to satisfaction of these other closing conditions, the acquisition is expected to close in the first calendar quarter of 2013. As previously announced on October 25, 2012, McKesson and PSS World Medical have signed a definitive agreement under which McKesson will acquire all outstanding shares of PSS World Medical for $29.00 per share in cash. Full Article
McKesson Corp Declares Quarterly Dividend October 26, 2012
McKesson Corp announced that the Board of Directors declared a regular dividend of $0.20 per share on Common Stock, payable on January 2, 2013, to stockholders of record on December 3, 2012. Full Article
McKesson Corp Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates
McKesson Corp announced that based on performance to date, it is updating previous outlook for fiscal 2013 and now expect adjusted Earnings per diluted share (EPS) of $7.15 to $7.35 for fiscal 2013. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $7.26 for fiscal 2013. Full Article
McKesson Corp Announces To Purchase Pss World Medical Inc
McKesson Corp and PSS World Medical, Inc. announced that the two companies have signed a definitive agreement under which McKesson will acquire all outstanding shares of PSS World Medical for $29.00 per share in cash. PSS World Medical and McKesson`s Medical Surgical business will combine to form a leading provider of medical supplies, services and technology to physician and extended care customers. The total transaction, including the assumption of PSS World Medical`s outstanding debt, is valued at approximately $2.1 billion. The transaction, which has been approved by the boards of directors of both companies, is subject to customary closing conditions, including all necessary regulatory clearances and the approval of PSS World Medical`s shareholders. By the fourth year following the close of the transaction, McKesson expects to realize annual pre-tax synergies in excess of $100 million. Full Article
McKesson Corp To Pay $151 Million To States In Drug Pricing Accord-Reuters
Reuters reported that McKesson Corp has agreed to pay $151 million to settle state claims that it inflated pricing information for over 1,400 brand name drugs, causing Medicaid to overpay for the drugs. New York Attorney General Eric Schneiderman said the settlement resolves claims by 30 states that McKesson violated state and federal false claims acts. New York and California led negotiations for the states, Schneiderman said in a statement announcing the settlement. In April, McKesson agreed to pay $190 million to settle with the federal government over its portion of Medicaid costs. 'This settlement holds McKesson accountable for attempting to make millions of dollars in illegal profits,' Schneiderman said in the statement. Full Article
McKesson Corporation Reaffirms FY 2013 EPS Guidance
McKesson Corporation announced that for fiscal 2013, it continues to expect Adjusted Earnings per diluted share (EPS) of $7.05 to $7.35. According to I/B/E/S Estimates, analysts were expecting the Company to report EPS of $7.23 for fiscal 2013. Full Article
CORRECTED-BRIEF-McKesson Q4 results
(In May 7 story, corrects seventh bullet point to show analysts' estimate for 2014 profit was $8.06 per share, not $7.21)
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
